Easton Pharmaceutica Stock Performance
| EAPH Stock | USD 0.0001 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Easton Pharmaceutica are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Easton Pharmaceutica has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Easton Pharmaceutica is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Last Split Factor 1:3000 | Last Split Date 2009-04-30 |
1 | Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Bloomberg | 11/15/2024 |
| Begin Period Cash Flow | 280.2 K | |
| Total Cashflows From Investing Activities | -18.8 K | |
| Free Cash Flow | -188.5 K |
Easton |
Easton Pharmaceutica Relative Risk vs. Return Landscape
If you would invest 0.01 in Easton Pharmaceutica on September 4, 2024 and sell it today you would earn a total of 0.00 from holding Easton Pharmaceutica or generate 0.0% return on investment over 90 days. Easton Pharmaceutica is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Easton, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Easton Pharmaceutica Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Easton Pharmaceutica's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Easton Pharmaceutica, and traders can use it to determine the average amount a Easton Pharmaceutica's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| EAPH |
Based on monthly moving average Easton Pharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Easton Pharmaceutica by adding Easton Pharmaceutica to a well-diversified portfolio.
Easton Pharmaceutica Fundamentals Growth
Easton Stock prices reflect investors' perceptions of the future prospects and financial health of Easton Pharmaceutica, and Easton Pharmaceutica fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Easton Stock performance.
| Return On Equity | -0.0269 | ||||
| Return On Asset | -0.0083 | ||||
| Current Valuation | 2.14 M | ||||
| Shares Outstanding | 1.34 B | ||||
| Price To Earning | (22.00) X | ||||
| Price To Book | 0 X | ||||
| Price To Sales | 0.06 X | ||||
| Gross Profit | 201.4 K | ||||
| EBITDA | (188.54 K) | ||||
| Net Income | (188.54 K) | ||||
| Cash And Equivalents | 5.81 K | ||||
| Total Debt | 3.28 M | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 0.69 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (188.54 K) | ||||
| Market Capitalization | 134.49 K | ||||
| Total Asset | 10.19 M | ||||
| Retained Earnings | (39.82 M) | ||||
| Working Capital | (194.5 K) | ||||
| Current Asset | 297 K | ||||
| Current Liabilities | 137 K | ||||
About Easton Pharmaceutica Performance
By evaluating Easton Pharmaceutica's fundamental ratios, stakeholders can gain valuable insights into Easton Pharmaceutica's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Easton Pharmaceutica has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Easton Pharmaceutica has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.55 | 0.53 | |
| Return On Tangible Assets | (0.08) | (0.08) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.03) | (0.03) |
Things to note about Easton Pharmaceutica performance evaluation
Checking the ongoing alerts about Easton Pharmaceutica for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Easton Pharmaceutica help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Easton Pharmaceutica generated a negative expected return over the last 90 days | |
| Easton Pharmaceutica has some characteristics of a very speculative penny stock | |
| Easton Pharmaceutica has a very high chance of going through financial distress in the upcoming years | |
| Easton Pharmaceutica currently holds 3.28 M in liabilities with Debt to Equity (D/E) ratio of 0.43, which is about average as compared to similar companies. Easton Pharmaceutica has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Easton Pharmaceutica's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (188.54 K) with profit before overhead, payroll, taxes, and interest of 201.4 K. | |
| Easton Pharmaceutica currently holds about 5.81 K in cash with (188.54 K) of positive cash flow from operations. | |
| Easton Pharmaceutica has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Bloomberg |
- Analyzing Easton Pharmaceutica's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Easton Pharmaceutica's stock is overvalued or undervalued compared to its peers.
- Examining Easton Pharmaceutica's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Easton Pharmaceutica's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Easton Pharmaceutica's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Easton Pharmaceutica's stock. These opinions can provide insight into Easton Pharmaceutica's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Easton Stock analysis
When running Easton Pharmaceutica's price analysis, check to measure Easton Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easton Pharmaceutica is operating at the current time. Most of Easton Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Easton Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easton Pharmaceutica's price. Additionally, you may evaluate how the addition of Easton Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |